Spire Parkway Hospital is able to offer the new prostate cancer test PCA3Plus. It is believed to be more effective and specific than the more commonly available PSA (Prostate Specific Antigen) test.
The new test measures a genetic chemical messenger RNA which transfers DNA instructions from the PCA3 gene. Elevated scores are produced only when cancer is present.
For more information about the PCA3Plus prostate cancer test at Spire Parkway Hospital, please complete our online enquiry form.